Candidate HIV-1 gp140ΔV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge

HLA-A2.1–restricted Education and Cytolytic Activity of CD8+ T Lymphocytes from β2 Microglobulin (β2m) HLA-A2.1 Monochain Transgenic H-2Db β2m Double Knockout Mice

Steve Pascolo, Nathalie Bervas, Jan Ure et al. · The Journal of Experimental Medicine · 1997 · 483 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Primary Human Immunodeficiency Virus Type 2 (HIV-2) Isolates, Like HIV-1 Isolates, Frequently Use CCR5 but Show Promiscuity in Coreceptor Usage

Andreas Mörner, Åsa Björndal, Jan Albert et al. · Journal of Virology · 1999 · 328 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +12

CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans

Heather L. Davis, Irma Herawati Suparto, Risini D. Weeratna et al. · Vaccine · 2000 · 188 citations

Veterinary Medicine, Immunology, Molecular Biology +13

Native HIV-1 Tat Protein Targets Monocyte-Derived Dendritic Cells and Enhances Their Maturation, Function, and Antigen-Specific T Cell Responses

Emanuele Fanales‐Belasio, Sonia Moretti, Filomena Nappi et al. · The Journal of Immunology · 2002 · 154 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

Indresh K. Srivastava, Leonidas Stamatatos, Elaine Kan et al. · Journal of Virology · 2003 · 150 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16